Alprazolam and Epa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alprazolam (alprazolam) and Epa (epa (eicosapentaenoic acid)). Common drug interactions include foetal exposure during pregnancy among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Alprazolam and Epa. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.

What is Epa?

Epa has active ingredients of epa (eicosapentaenoic acid). It is often used in high blood cholesterol. eHealthMe is studying from 623 Epa users. Check the latest studies of Epa.

On Aug, 12, 2026

31 people who take Alprazolam and Epa together, and have interactions are studied.

What are the common drug interactions of Alprazolam and Epa, by gender? *:

female:

Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Drug ineffective
Neonatal tachypnoea (a slow breathing in neonate)
Insomnia (sleeplessness)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Arthralgia (joint pain)
Dizziness
Hallucination (an experience involving the perception of something not present)
Head discomfort
Pain

male:

Dizziness
Abdominal pain upper
Palpitations (feelings or sensations that your heart is pounding or racing)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Somnolence (a state of near-sleep, a strong desire for sleep)
Thrombocytopenia (decrease of platelets in blood)
Urethral pain
Vomiting
Arrhythmia (irregular heartbeat)

What are the common drug interactions of Alprazolam and Epa, by age (0-1 to 60+)? *:

0-1:

Drug withdrawal syndrome neonatal (prenatal nas is caused by discontinuation of drugs taken by the pregnant mother)
Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)

2-9:

n/a

10-19:

n/a

20-29:

Altered state of consciousness (altered state of mind)
Bradycardia (abnormally slow heart action)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pruritus generalised (generalized itching)

30-39:

Rash

40-49:

Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Dyspnoea (difficult or laboured respiration)
Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

Drug ineffective
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Compulsions (performing an act persistently and repetitively)
Decreased appetite
Decreased interest
Delusion (a false belief or opinion)
Depressed mood
Depression
Depression suicidal (suicide depressive disorder)
Dilated cardiomyopathy

60+:

Dizziness
Insomnia (sleeplessness)
Palpitations (feelings or sensations that your heart is pounding or racing)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Somnolence (a state of near-sleep, a strong desire for sleep)
Thrombocytopenia (decrease of platelets in blood)
Urethral pain
Vomiting
Angina pectoris (chest pain due to ischemia of the heart muscle)

What are the existing conditions these people have? *

Panic Disorder: 6 people, 19.35%
Insomnia (sleeplessness): 4 people, 12.90%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 4 people, 12.90%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 9.68%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 9.68%
Pituitary Tumor Benign: 3 people, 9.68%
Neuralgia (pain in one or more nerves): 3 people, 9.68%
Migraine (headache): 3 people, 9.68%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 3 people, 9.68%
Prostate Cancer: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Alprazolam and Epa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously